About
Out licensing
Areas of Focus
Categories
Small Molecule PharmaceuticalNJ, NY, PA
Team (6)
Dennis H
Dennis H. Langer, M.D., J.D.
Braeburn Pharmaceuticals
team_member
Jerry Karabelas
Jerry Karabelas, Ph.D.
Braeburn Pharmaceuticals
team_member
Joseph Yanchik
Joseph Yanchik
Braeburn Pharmaceuticals
team_member
Mike Derkacz
Mike Derkacz
Braeburn Pharmaceuticals
team_member
Patrick J
Patrick J. Kennedy
Braeburn Pharmaceuticals
team_member
Seth Harrison
Seth Harrison, MD
Braeburn Pharmaceuticals
team_member
Clinical Trials (9)
View allTotal Trials
9
As Lead Sponsor
8
As Collaborator
1
Total Enrollment
2,050
By Phase
PHASE3: 4NA: 1PHASE1: 1PHASE2: 3
By Status
COMPLETED: 8UNKNOWN: 1
Clinical Trials Pipeline9 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2014
2015
2016
2017
2018
2019
2020
Today
Hover over trial bars to see details
Recent Trials
NCT02946073Lead Sponsor
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
PHASE3Completed
1,053 participants
Started: Sep 30, 2016 · Completed: Feb 28, 2019
NCT02896660Collaborator
Probuphine Innovations for Clinical Effectiveness (PRINCE)
NAUnknown
15 participants
Started: Sep 30, 2016 · Completed: Apr 30, 2017
NCT02824666Lead Sponsor
Study to Evaluate D2 Receptor Occupancy Following Single Intravenous Administration of ATI-9242
PHASE1Completed
7 participants
Started: Jun 20, 2016 · Completed: Nov 8, 2016
NCT02773576Lead Sponsor
Safety and Tolerability of Risperidone Implants
PHASE3Completed
140 participants
Started: Apr 30, 2016 · Completed: Sep 30, 2017
NCT02651584Lead Sponsor
Clinical Trial of CAM2038, Long-acting Subcutaneous Buprenorphine Injections for Treatment of Patients With Opioid Dependence
PHASE3Completed
428 participants
Started: Dec 31, 2015 · Completed: Nov 30, 2016
Locations (1)
Headquarters
Plymouth Meeting, PA, United States
Map
Loading map...